Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Courtesy of Color Genomics
Color Genomics, a Silicon Valley startup that provides genetic tests for consumers, has secured $52 million of what is expected to be an $80 million funding round.
Doctor disintermediation: Founded in 2013, Color Genomics sells genetics testing kits that screen for hereditary high cholesterol and common hereditary cancers. It's part of a growing industry of companies, like 23andMe, providing health services and information to patients that were previously only available through doctors.
Deal details: CRV and existing investors General Catalyst and Emerson Collective co-led the new round. The company previously raised around $60 million, with other shareholders including Khosla Ventures, Formation 8 and Eric Schmidt's Innovation Endeavors.